After a 12 h incubation with AGEs and/or HQ, ARPE-19 cells were harvested, and total RNA was prepared as described [21] (
link), [22] (
link), [28] (
link). The PCR primers corresponding to nucleotides 1131–1151 and 1186–1206 for human
VEGF-A mRNA (NM_001025370), 305–329 and 374–395 for human
specificity protein 1 (
SP1) mRNA (NM_138473), and 420–437 and 492–509 for human
ß-actin mRNA (NM_001101) were synthesized by Nihon Gene Research Laboratories (NGRL) (Sendai, Japan) as described [20] (
link), [21] (
link), [22] (
link), [26] (
link), [27] (
link), [28] (
link), [29] , [30] , [31] (
link). Real-time reverse transcription polymerase chain reaction (RT-PCR) was performed using SYBR
® Fast qPCR kit (KAPA Biosystems, Wilmington, MA) and Thermal Cycle Dice
® Real Time System (Takara Bio Inc.) as described [20] (
link), [21] (
link), [22] (
link), [28] (
link), [30] . Target cDNAs were cloned into pBluescript SK(-) plasmid (Stratagene, La Jolla, CA) and sequential 10-fold dilutions from 10
2–10
7 copies/µL were prepared. The serial dilutions were run to verify the specificity and to test the sensitivity of the SYBR Green-based real-time RT-PCR. The mRNA expression levels were normalized to the mRNA level of
ß-actin, which was used to account for difference in the efficiency of reverse transcription between samples.
Tsujinaka H., Itaya-Hironaka A., Yamauchi A., Sakuramoto-Tsuchida S., Ota H., Takeda M., Fujimura T., Takasawa S, & Ogata N. (2015). Human retinal pigment epithelial cell proliferation by the combined stimulation of hydroquinone and advanced glycation end-products via up-regulation of VEGF gene. Biochemistry and Biophysics Reports, 2, 123-131.